Key facts
- Long-term uranium prices hit a record $96/lb, up 12% year-to-date.
- Spot uranium prices are around $90/lb, up 11% year-to-date.
- Utilities are reportedly experiencing sticker shock and are reluctant to contract uranium at current high prices.
- Term contracting volumes for 2026 are tracking at the lowest point in five years.
- Nuclear-related equities, including NuScale and Oklo, are down significantly year-to-date.
- Holtec International postponed its $10 billion IPO, citing a market correction and cooling investor enthusiasm for the AI trade.
Despite uranium prices reaching an all-time record of $96/lb, the stocks of nuclear energy companies and related projects are experiencing a significant downturn. This divergence, highlighted by TD Cowen's uranium team, suggests a disconnect between the commodity's value and investor sentiment towards the nuclear sector.
While long-term uranium prices have climbed approximately 12% year-to-date, and spot prices are up around 11% to $90/lb, utilities are reportedly hesitant to enter into new contracts due to high prices, leading to a slowdown in contracting volumes. Term volumes for 2026 are tracking at their lowest in five years, indicating a potential future supply crunch if utilities continue to contract below replacement rates.
In contrast, the equity market for nuclear-related companies has suffered. The broad nuclear ETF (NLR) has fallen 12% year-to-date, while AI-focused ETFs have gained significantly, suggesting investors are prioritizing faster power solutions over long-term nuclear projects. Companies like NuScale and Oklo have seen their stock prices drop substantially, and Holtec International recently withdrew its $10 billion IPO, with its CEO citing a market correction and waning investor enthusiasm for the "AI power trade."
Analysts at Goldman Sachs noted that investor interest in the nuclear sector has been "extremely light" recently, attributing it to broader market concerns such as interest rates and inflation, as well as a focus on quicker-to-deploy energy solutions like reciprocating engines, turbines, fuel cells, and batteries. However, Goldman Sachs also pointed to potential increases in nuclear capacity through uprates and restarts, which would still require more uranium.
On the supply side, challenges persist. Kazatomprom, a major uranium producer, has delayed the commissioning of its sulfuric acid plant by six to twelve months, which could further tighten supply.